We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Micro-nanoplastics and Parkinson’s disease: evidence and perspectives
Summary
Researchers reviewed growing evidence linking micro- and nanoplastic exposure to Parkinson's disease, a degenerative brain condition. Lab studies suggest these particles may accelerate disease by promoting the misfolding of a key brain protein (alpha-synuclein), triggering inflammation, and damaging mitochondria — though large-scale human studies are still needed to establish causation and define safe exposure thresholds.
With the intensification of global plastic pollution, the potential threats posed by micro- and nanoplastics (MPs/NPs) to human health have become a major concern. MPs/NPs enter the organism through ingestion, inhalation, and skin contact, subsequently accumulating in multiple organs-particularly the brain. Increasing experimental and epidemiological evidence implicates MPs/NPs in the development of Parkinson's disease (PD). Preclinical research models indicate that MPs/NPs may accelerate both the initiation and progression of PD by facilitating α-synuclein misfolding and aggregation, triggering neuroinflammatory cascades, elevating oxidative stress, and impairing mitochondrial function. To further investigate the causal role of MPs/NPs in PD, upcoming studies should emphasize well-designed, large-scale prospective cohorts to assess individual exposure to plastic-related pollutants, elucidate the pathways of MPs/NPs into the central nervous system, establish safety thresholds for their neurotoxicity, explore the correlation between exposure levels and central nervous system accumulation, clarify the temporal relationship between MPs/NPs accumulation and PD pathology and symptom onset, and identify the neuropathological mechanisms triggered by relevant concentrations of MPs/NPs. Such data will be instrumental in informing preventive and potentially interventional strategies, while offering actionable insights into the interaction between MPs/NPs and PD.
Sign in to start a discussion.
More Papers Like This
Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation
Researchers discovered that nanoplastics can enter brain cells and accelerate the clumping of alpha-synuclein, a protein whose buildup is the hallmark of Parkinson's disease. In mice, nanoplastics worsened the spread of this protein pathology across brain regions, including the area that controls movement, suggesting a potential link between nanoplastic pollution and Parkinson's disease risk.
Microplastic Exposure and the of Parkinson’s Disease
This review examines evidence linking microplastic exposure to Parkinson's disease pathology, noting that animal studies show microplastics can decrease dopaminergic neurons and impair motor function through mechanisms resembling the disease's progression.
Uncovering the impact of nano- and microplastics on neurodegenerative diseases and strategies to mitigate their damage
Researchers reviewed evidence that micro- and nanoplastics may contribute to the progression of Alzheimer's and Parkinson's diseases by triggering brain inflammation, disrupting mitochondria (the cell's power source), and damaging the blood-brain barrier. The review also found that natural compounds like melatonin and probiotics show early promise in reducing some of these harmful effects.
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
This study found that nanoplastic particles can accelerate the clumping of a protein called alpha-synuclein, which is linked to Parkinson's disease. Using advanced mass spectrometry, researchers showed that nanoplastics sped up the formation of harmful protein clusters and increased their toxicity to brain cells. The findings suggest that nanoplastic exposure could be a factor worth investigating in neurodegenerative disease research.
Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
This review explores the emerging connection between microplastic exposure and neurodegenerative diseases such as Alzheimer's and Parkinson's, identifying shared pathophysiological pathways. Researchers found that microplastics can cross the blood-brain barrier and may trigger oxidative stress, neuroinflammation, and protein aggregation, which are hallmarks of these conditions. The study suggests that chronic microplastic exposure could be a contributing environmental factor in neurodegeneration, though direct causal evidence in humans is still lacking.